Home
Conditions
Adrenocortical Carcinoma

Clinical trial condition

Adrenocortical Carcinoma

Explore clinical trials studying Adrenocortical Carcinoma. Study availability and eligibility vary by location and protocol.

69 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Adrenocortical Carcinoma trial results

Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT04119024

Conditions: Acral Melanoma, Adenocarcinoma, Adenocarcinoma of Lung, +59 more
Locations: City of Hope Duarte, California, United States

UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Stanford, California, United States

View Trial Details

Recruiting

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

NCT06006013

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +15 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma

NCT07335679

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
Locations: Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France Strasbourg, France

View Trial Details

Recruiting

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations: Institut de Cancérologie de l'Ouest Angers, France

Institut du Cancer Avignon-Provence Avignon, France

CHU Jean Minjoz Besançon, France

CHU Morvan Brest, France

View all 22 locations

View Trial Details

Recruiting

Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer

NCT07085572

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
Locations: S.C. Oncologia - ASST Spedali Civili di Brescia Brescia, Italy

View Trial Details

Recruiting

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

NCT06831175

Conditions: Adenocarcinoma, Adrenal Cancer, Adrenal Cortex Diseases, +13 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

NCT06587802

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.

NCT05563467

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Maria Sklodowska-Curie National Research Institute of Oncology Gliwice, Silesian Voivodeship, Poland

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie Cracow, Poland

Uniwersytecki Szpital Kliniczny W Poznaniu Poznan, Poland

Medical University Of Warsaw Warsaw, Poland

View Trial Details

Recruiting

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

NCT05913427

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: Alfredo Berruti Brescia, Italy

View Trial Details

Recruiting

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

NCT04318730

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Adrenocortical Carcinoma

Adrenocortical Carcinoma trial results

Related conditions